We are live on ! Find out more
ARAY icon

Accuray

0.2305 USD
-0.0148
6.03%
At close Updated Sep 15, 4:00 PM EDT
Pre-market
After hours
0.2351
+0.0046
2%
1 day
-6.03%
5 days
-12.02%
1 month
-29.42%
3 months
-28.35%
6 months
-44.67%
Year to date
-72.84%
1 year
-85.68%
5 years
-93.41%
10 years
-95.78%
 

About: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

Employees: 809

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
PRNewsWire
4 days ago
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
Neutral
Seeking Alpha
26 days ago
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Neutral
PRNewsWire
27 days ago
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
MADISON, Wis., Aug. 19, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026.
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
Neutral
PRNewsWire
1 month ago
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth.
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
Neutral
PRNewsWire
1 month ago
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
MADISON, Wis., Aug. 5, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m.
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
Neutral
PRNewsWire
1 month ago
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
MADISON, Wis., July 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating several decisive actions that will drive a significant improvement in its financial position, a fundamental change in its business strategy, the rollout of differentiated technology, and continued transformation in how the company operates.
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
Neutral
PRNewsWire
3 months ago
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Neutral
PRNewsWire
4 months ago
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Neutral
Seeking Alpha
4 months ago
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Neutral
PRNewsWire
4 months ago
Accuray Reports Fiscal 2026 Third Quarter Financial Results
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.
Accuray Reports Fiscal 2026 Third Quarter Financial Results
Price charts implemented using Lightweight Charts™